Effects of exercise training on SFO-mediated sympathoexcitation during chronic heart failure

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 306, Issue 1, 2014, Pages

  Llewellyn, Tamra L ^a   Sharma, Neeru M ^a   Zheng, Hong ^a   Patel, Kaushik P ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Angiotensin II; FosB; Paraventricular nucleus; Renal sympathetic nerve activity; Subfornical organ

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; CITRATE SYNTHASE; LOSARTAN; MESSENGER RNA; NORADRENALIN; RECEPTOR PROTEIN; TRANSCRIPTION FACTOR FOSB;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; EXERCISE; HEART FAILURE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART RATE; HEMODYNAMIC PARAMETERS; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; KIDNEY NERVE; MALE; MEAN ARTERIAL PRESSURE; MICROINJECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SHAM PROCEDURE; SUBFORNICAL ORGAN; SYMPATHETIC INNERVATION; SYMPATHETIC NERVE; SYMPATHETIC TONE; WESTERN BLOTTING;

EID: 84891542097     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00534.2013     Document Type: Article

References (50)

1. Badoer E. Hypothalamic paraventricular nucleus and cardiovascular regulation. Clin Exp Pharmacol Physiol 28: 95-99, 2001.
2. Bains JS, Ferguson AV. Paraventricular nucleus neurons projecting to the spinal cord receive excitatory input from the subfornical organ. Am J Physiol Regul Integr Comp Physiol 268: R625-R633, 1995.
3. Belardinelli R, Georgiou D, Cianci G, Purcaro A. Randomized, controlled trial of long-term moderate exercise training in chronic heart failure: effects on functional capacity, quality of life, and clinical outcome. Circulation 99: 1173-1182, 1999.
4. Benicky J, Hafko R, Sanchez-Lemus E, Aguilera G, Saavedra JM. Six commercially available angiotensin II AT1 receptor antibodies are nonspecific. Cell Mol Neurobiol 32: 1353-1365, 2012.
5. Blume A, Seifert K, Lebrun CJ, Mollenhoff E, Gass P, Unger T, Herdegen T. Differential time course of angiotensin-induced AP-1 and Krox proteins in the rat lamina terminalis and hypothalamus. Neurosci Lett 241: 87-90, 1998.
6. Brändle M, Patel KP, Wang W, Zucker IH. Hemodynamic and norepinephrine responses to pacing-induced heart failure in conscious sinoaorticdenervated dogs. J Appl Physiol 81: 1855-1862, 1996.
7. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311: 819-823, 1984.
8. Davisson RL, Zimmerman MC. Angiotensin II, oxidant signaling, and hypertension: down to a T? Hypertension 55: 228-230, 2010.
9. Geyssant A, Geelen G, Denis C, Allevard AM, Vincent M, Jarsaillon E, Bizollon CA, Lacour JR, Gharib C. Plasma vasopressin, renin activity, and aldosterone: effect of exercise and training. Eur J Appl Physiol Occup Physiol 46: 21-30, 1981.
10. Haack KK, Engler CW, Papoutsi E, Pipinos II, Patel KP, Zucker IH. Parallel changes in neuronal AT1R and GRK5 expression following exercise training in heart failure. Hypertension 60: 354-361, 2012.
11. Huang BS, Ahmadi S, Ahmad M, White RA, Leenen FH. Central neuronal activation and pressor responses induced by circulating ANG II: role of the brain aldosterone-"ouabain" pathway. Am J Physiol Heart Circ Physiol 299: H422-H430, 2010.
12. Kang YM, Zhang ZH, Xue B, Weiss RM, Felder RB. Inhibition of brain proinflammatory cytokine synthesis reduces hypothalamic excitation in rats with ischemia-induced heart failure. Am J Physiol Heart Circ Physiol 295: H227-H236, 2008.
13. Kar S, Gao L, Zucker IH. Exercise training normalizes ACE and ACE2 in the brain of rabbits with pacing-induced heart failure. J Appl Physiol 108: 923-932, 2010.
14. Kinugawa T, Kato M, Ogino K, Osaki S, Igawa O, Hisatome I, Shigemasa C. Plasma endothelin-1 levels and clinical correlates in patients with chronic heart failure. J Card Fail 9: 318-324, 2003.
15. Kleiber AC, Zheng H, Schultz HD, Peuler JD, Patel KP. Exercise training normalizes enhanced glutamate-mediated sympathetic activation from the PVN in heart failure. Am J Physiol Regul Integr Comp Physiol 294: R1863-R1872, 2008.
16. Ku YH, Jia YF, Chang YZ. Mechanisms underlying pressor response of subfornical organ to angiotensin II. Peptides 20: 171-176, 1999.
17. Levett JM, Marinelli CC, Lund DD, Pardini BJ, Nader S, Scott BD, Augelli NV, Kerber RE, Schmid PG Jr. Effects of β-blockade on neurohumoral responses and neurochemical markers in pacing-induced heart failure. Am J Physiol Heart Circ Physiol 266: H468-H475, 1994.
18. Li YF, Jackson KL, Stern JE, Rabeler B, Patel KP. Interaction between glutamate and GABA systems in the integration of sympathetic outflow by the paraventricular nucleus of the hypothalamus. Am J Physiol Heart Circ Physiol 291: H2847-H2856, 2006.
19. Li YF, Mayhan WG, Patel KP. NMDA-mediated increase in renal sympathetic nerve discharge within the PVN: role of nitric oxide. Am J Physiol Heart Circ Physiol 281: H2328-H2336, 2001.
20. Liu D, Gao L, Roy SK, Cornish KG, Zucker IH. Neuronal angiotensin II type 1 receptor upregulation in heart failure: activation of activator protein 1 and Jun N-terminal kinase. Circ Res 99: 1004-1011, 2006.
21. Liu JL, Irvine S, Reid IA, Patel KP, Zucker IH. Chronic exercise reduces sympathetic nerve activity in rabbits with pacing-induced heart failure-a role for angiotensin II. Circulation 102: 1854-1862, 2000.
22. Llewellyn T, Zheng H, Liu X, Xu B, Patel KP. Median preoptic nucleus and subfornical organ drive renal sympathetic nerve activity via a glutamatergic mechanism within the paraventricular nucleus. Am J Physiol Regul Integr Comp Physiol 302: R424-R432, 2012.
23. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 121: e46-e215, 2010.
24. McKinley MJ, Pennington GL, Oldfield BJ. Anteroventral wall of the third ventricle and dorsal lamina terminalis: headquarters for control of body fluid homeostasis? Clin Exp Pharmacol Physiol 23: 271-281, 1996.
25. Miselis RR. The efferent projections of the subfornical organ of the rat: a circumventricular organ within a neural network subserving water balance. Brain Res 230: 1-23, 1981.
26. Mitra AK, Gao L, Zucker IH. Angiotensin II-induced upregulation of AT1 receptor expression: sequential activation of NF-κB and Elk-1 in neurons. Am J Physiol Cell Physiol 299: C561-C569, 2010.
27. Musch TI, Terrell JA. Skeletal muscle blood flow abnormalities in rats with a chronic myocardial infarction: rest and exercise. Am J Physiol Heart Circ Physiol 262: H411-H419, 1992.
28. National Center for Health Statistics, Centers for Disease Control and Prevention. Health, United States, 2010: With Special Feature on Death and Dying (online). www.cdc.gov/nchs/data/hus/hus10.pdf [28 October 2013].
29. Nestler EJ, Barrot M, Self DW. ΔFosB: a sustained molecular switch for addiction. Proc Natl Acad Sci USA 98: 11042-11046, 2001.
30. Nestler EJ, Kelz MB, Chen J. ΔFosB: a molecular mediator of long-term neural and behavioral plasticity. Brain Res 835: 10-17, 1999.
31. Palkovits M, Brownstein M. Brain microdissection techniques. In: Brain Microdissection Techniques, edited by Cuello AE. Chichester: John Wiley & Sons, 1983, p. 37-42.
32. Patel KP, Zhang K, Zucker IH, Krukoff TL. Decreased gene expression of neuronal nitric oxide synthase in hypothalamus and brainstem of rats in heart failure. Brain Res 734: 109-115, 1996.
33. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. Orlando, FL: Academic, 1986.
34. Pereira MG, Ferreira JC, Bueno CR Jr, Mattos KC, Rosa KT, Irigoyen MC, Oliveira EM, Krieger JE, Brum PC. Exercise training reduces cardiac angiotensin II levels and prevents cardiac dysfunction in a genetic model of sympathetic hyperactivity-induced heart failure in mice. Eur J Appl Physiol 105: 843-850, 2009.
35. Rosenbaugh EG, Roat JW, Gao L, Yang RF, Manickam DS, Yin JX, Schultz HD, Bronich TK, Batrakova EV, Kabanov AV, Zucker IH, Zimmerman MC. The attenuation of central angiotensin II-dependent pressor response and intra-neuronal signaling by intracarotid injection of nanoformulated copper/zinc superoxide dismutase. Biomaterials 31: 5218-5226, 2010.
36. Sharma NM, Zheng H, Li YF, Patel KP. Nitric oxide inhibits the expression of AT1 receptors in neurons. Am J Physiol Cell Physiol 302: C1162-C1173, 2012.
37. Smith PM, Ferguson AV. Circulating signals as critical regulators of autonomic state-central roles for the subfornical organ. Am J Physiol Regul Integr Comp Physiol 299: R405-R415, 2010.
38. Srere PA. Citrate synthase. Methods Enzymol 13: 3-11, 1969.
39. Sumners C, Fleegal MA, Zhu M. Angiotensin AT1 receptor signalling pathways in neurons. Clin Exp Pharmacol Physiol 29: 483-490, 2002.
40. Vahid-Ansari F, Leenen FHH. Pattern of neuronal activation in rats with CHF after myocardial infarction. Am J Physiol Heart Circ Physiol 275: H2140-H2146, 1998.
41. Wei SG, Yu Y, Zhang ZH, Felder RB. Angiotensin II upregulates hypothalamic AT1 receptor expression in rats via the mitogen-activated protein kinase pathway. Am J Physiol Heart Circ Physiol 296: H1425-H1433, 2009.
42. Wei SG, Yu Y, Zhang ZH, Weiss RM, Felder RB. Mitogen-activated protein kinases mediate upregulation of hypothalamic angiotensin II type 1 receptors in heart failure rats. Hypertension 52: 679-686, 2008.
43. Wei SG, Zhang ZH, Beltz TG, Yu Y, Johnson AK, Felder RB. Subfornical organ mediates sympathetic and hemodynamic responses to blood-borne proinflammatory cytokines. Hypertension 62: 118-125, 2013.
44. Westerhaus MJ, Loewy AD. Sympathetic-related neurons in the preoptic region of the rat identified by viral transneuronal labeling. J Comp Neurol 414: 361-378, 1999.
45. Yin JX, Yang RF, Li S, Renshaw AO, Li YL, Schultz HD, Zimmerman MC. Mitochondria-produced superoxide mediates angiotensin IIinduced inhibition of neuronal potassium current. Am J Physiol Cell Physiol 298: C857-C865, 2010.
46. Yoshimura R, Sato T, Kawada T, Shishido T, Inagaki M, Miyano H, Nakahara T, Miyashita H, Takaki H, Tatewaki T, Yanagiya Y, Sugimachi M, Sunagawa K. Increased brain angiotensin receptor in rats with chronic high-output heart failure. J Card Fail 6: 66-72, 2000.
47. Zheng H, Li YF, Wang W, Patel KP. Enhanced angiotensin-mediated excitation of renal sympathetic nerve activity within the paraventricular nucleus of anesthetized rats with heart failure. Am J Physiol Regul Integr Comp Physiol 297: R1364-R1374, 2009.
48. Zheng H, Sharma NM, Liu X, Patel KP. Exercise training normalizes enhanced sympathetic activation from the paraventricular nucleus in chronic heart failure: role of angiotensin II. Am J Physiol Regul Integr Comp Physiol 303: R387-R394, 2012.
49. Zimmerman MC, Lazartigues E, Sharma RV, Davisson RL. Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system. Circ Res 95: 210-216, 2004.
50. Zucker IH, Schultz HD, Patel KP, Wang W, Gao L. Regulation of central angiotensin type 1 receptors and sympathetic outflow in heart failure. Am J Physiol Heart Circ Physiol 297: H1557-H1566, 2009.